Staar Surgical Co. (STAA) intrinsic value & 10-year financials
Staar Surgical Co. (STAA) has a Graham intrinsic value of $13.37 per share. At $21.27 on Oct 17, 2026, the stock trades 59% above that value. Over the last 10 fiscal years revenue grew 13.8% a year to $239.4M, with an average return on invested capital of 3.3%.
- Graham intrinsic value
- $13.37
- Share price (Oct 17, 2026)
- $21.27
- Price vs Graham value
- 59% above
- Market cap
- $1.1B
- Revenue (FY2026)
- $239.4M
- Revenue growth (10-yr CAGR)
- 13.8%
- ROIC (10-yr avg)
- 3.3%
- Free cash flow (FY2026)
- -$40.0M
STAA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2026 | $239.4M | -$80.4M | -$1.62 | -$40.0M | -38.3% | -35.1% |
| FY2024 | $313.9M | -$20.2M | -$0.41 | -$7.7M | -4.0% | -4.8% |
| FY2023 | $322.4M | $21.3M | $0.43 | -$3.6M | 8.7% | 7.0% |
| FY2022 | $284.4M | $38.8M | $0.78 | $17.6M | 15.4% | 20.7% |
| FY2021 | $230.5M | $24.5M | $0.50 | $30.3M | 14.5% | 39.6% |
| FY2020 | $20.9M | $14.0M | $0.30 | $15.7M | 56.8% | 32.3% |
| FY2018 | $22.9M | $5.0M | $0.11 | $10.5M | 28.8% | 17.0% |
| FY2017 | $22.3M | -$2.1M | -$0.05 | $1.8M | -16.3% | -8.3% |
| FY2016 | $77.1M | -$6.5M | -$0.17 | -$4.2M | -6.9% | -14.1% |
| FY2015 | $75.0M | -$8.4M | -$0.22 | -$12.0M | -10.7% | -21.0% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
STAAR SURGICAL CO is a consistent compounder, expanding top-line revenue at 13.8% annually over the past decade.
STAAR SURGICAL CO has historically struggled to out-earn its cost of capital, averaging just 3.3% ROIC.
STAAR SURGICAL CO has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, STAAR SURGICAL CO is modeled at 13.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $13.37 per share.